Caxton Associates (New York)’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $738K | Buy |
39,934
+28,502
| +249% | +$526K | 0.02% | 264 |
|
|
2024
Q3 | $248K | Sell |
11,432
-13,663
| -54% | -$297K | 0.01% | 462 |
|
|
2024
Q2 | $492K | Buy |
+25,095
| New | +$492K | 0.02% | 340 |
|
|
2024
Q1 | – | Sell |
-8,488
| Closed | -$245K | – | 492 |
|
|
2023
Q4 | $245K | Buy |
+8,488
| New | +$245K | 0.01% | 411 |
|
|
2022
Q1 | – | Sell |
-5,799
| Closed | -$583K | – | 547 |
|
|
2021
Q4 | $583K | Buy |
+5,799
| New | +$583K | 0.06% | 216 |
|
|
2021
Q2 | – | Sell |
-4,843
| Closed | -$468K | – | 482 |
|
|
2021
Q1 | $468K | Buy |
4,843
+762
| +19% | +$73.6K | 0.04% | 151 |
|
|
2020
Q4 | $213K | Buy |
+4,081
| New | +$213K | 0.01% | 85 |
|